Scroll Top
19th Ave New York, NY 95822, USA

Man died of COVID-19 the same day a legal agreement was reached that allowed his family to seek treatment for the virus with Ivermectin

The 62-year-old man reportedly died of COVID-19 the same day a legal agreement was reached that allowed his family to seek treatment for the virus with Ivermectin. As we all know by now, the drug has been at the center of attention during the pandemic. Some used it for COVID-19 treatment, even buying it at farm supply stores. The federal government says it’s not approved to treat the virus.

The 62-year-old man from Mississippi, Wayne Doyle, died Tuesday afternoon at North Mississippi Medical Center. His family said Doyle died of COVID-19 the same day a legal agreement was reached that allowed them to seek treatment for the virus with Ivermectin, according to reports.
According to reports, the 62-year-old man was hospitalized with the virus at North Mississippi Medical Center. His family had asked the hospital to treat Doyle with Ivermectin — an anti-parasitic drug that has not been proven as an effective treatment against COVID-19.
According to reports, hospital reportedly refused to offer the treatments. But, oon Tuesday, an agreement was reached that allowed his family to move him from North Mississippi Medical Center to another hospital that would offer him Ivermectin. Unfortunately, the 62-year-old man died before his family could move him to another facility.

According to his obituary page, the 62-year-old man served as a volunteer firefighter for 40 years and also owned a local construction company.

Ivermectin is a drug commonly used as an anti-parasitic. Several clinical trials have taken place to gauge its effectiveness in fighting COVID-19, the FDA has not issued approval for its use in treating the virus.

The CDC also issued warnings about the non-clinical use of Ivermectin to treat COVID-19, noting that it had seen an increase in calls to poison control centers for Ivermectin overdoses.

This story will be updated as new information become available.